2Open roles

About Jasper Therapeutics

Jasper Therapeutics is a biotechnology company focused on enabling safer conditioning agents to allow for expanded use of curative therapy with stem cell transplants and gene therapies.

Founded in 2018 by Judith Shizuru M.D. and Susan Prohaska.

Founded
2018
Employees
11 to 50
Total funding
$289.1M

Leadership

The top of Jasper Therapeutics's org chart, with how many people report into each leader.

BLPhoto of Bill Lis

Bill Lis

Executive Chairman & CEO

29 reports

JHPhoto of Janet Hurt

Janet Hurt

VP, Clinical Operations

4 reports

WPPhoto of Wendy Pang

Wendy Pang

VP, Research & Translational Medicine

4 reports

HC

Herb Cross

Chief Financial Officer

3 reports

LNPhoto of Luca Di Noto

Luca Di Noto

VP, Technical Operations

2 reports

JMPhoto of Jeet Mahal

Jeet Mahal

Chief Financial & Business Officer

1 report

MF

Matt Ford

Vice President Human Resources

1 report

MCPhoto of Mark Camarena

Mark Camarena

Vice President of IT and Facilities at Jasper Therapeutics

1 report

TMPhoto of Tino Mori

Tino Mori

Senior Manager, Document Control

Board

AFPhoto of Anna French

Anna French

Director

KEPhoto of Kurt von Emster

Kurt von Emster

Director

JR

Jeffrey V. Ravetch

Scientific Advisor

AW

Art Weiss

Scientific Advisor

LK

Lori Kunkel

Scientific Advisor

FA

Fred Appelbaum

Scientific Advisor